Patent ID: 7488746
Filing Date: 2009-02-10
Classification: A61K,A61P,C07D

Abstract:
1. A method for the treatment of disorders of the central nervous system selected from the group consisting of anxiety and depression, comprising the administration of a pharmaceutical composition to a patient in need thereof consisting essentially of a compound of formula I or a pharmaceutically acceptable salt thereof wherein: R1 and R2 R3 is hydrogen, methyl, F, Cl, Br, I, CN, S(O) R4 is selected from the group consisting of hydrogen, cycloalkyl having 3, 4, 5, or 6 carbon atoms, alkenyl having 2, 3 or 4 carbon atoms, alkenylalkyl having 3 or 4 carbon atoms, ethynyl, alkylalkynyl having 3 or 4 carbon atoms, and —C R7 and R8 R7 and R8 R7 and R8